535 related articles for article (PubMed ID: 19592080)
1. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
[TBL] [Abstract][Full Text] [Related]
2. TLR-mediated B cell defects and IFN-α in common variable immunodeficiency.
Yu JE; Zhang L; Radigan L; Sanchez-Ramon S; Cunningham-Rundles C
J Clin Immunol; 2012 Feb; 32(1):50-60. PubMed ID: 22048980
[TBL] [Abstract][Full Text] [Related]
3. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
Gujer C; Sundling C; Seder RA; Karlsson Hedestam GB; Loré K
Immunology; 2011 Nov; 134(3):257-69. PubMed ID: 21977996
[TBL] [Abstract][Full Text] [Related]
4. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Derkow K; Bauer JM; Hecker M; Paap BK; Thamilarasan M; Koczan D; Schott E; Deuschle K; Bellmann-Strobl J; Paul F; Zettl UK; Ruprecht K; Lehnardt S
PLoS One; 2013; 8(8):e70626. PubMed ID: 23950974
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.
Xu N; Yao HP; Lv GC; Chen Z
Inflamm Res; 2012 Sep; 61(9):997-1004. PubMed ID: 22684144
[TBL] [Abstract][Full Text] [Related]
7. TLR9 activation is defective in common variable immune deficiency.
Cunningham-Rundles C; Radigan L; Knight AK; Zhang L; Bauer L; Nakazawa A
J Immunol; 2006 Feb; 176(3):1978-87. PubMed ID: 16424230
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.
Berghöfer B; Haley G; Frommer T; Bein G; Hackstein H
J Immunol; 2007 Apr; 178(7):4072-9. PubMed ID: 17371961
[TBL] [Abstract][Full Text] [Related]
9. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
[TBL] [Abstract][Full Text] [Related]
10. Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.
Taraldsrud E; Fevang B; Aukrust P; Beiske KH; Fløisand Y; Frøland S; Rollag H; Olweus J
Clin Exp Immunol; 2014 Mar; 175(3):439-48. PubMed ID: 24237110
[TBL] [Abstract][Full Text] [Related]
11. Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.
Kader M; Smith AP; Guiducci C; Wonderlich ER; Normolle D; Watkins SC; Barrat FJ; Barratt-Boyes SM
PLoS Pathog; 2013; 9(7):e1003530. PubMed ID: 23935491
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells.
Patamawenu AA; Wright NE; Shofner T; Evans S; Manion MM; Doria-Rose N; Migueles SA; Mendoza D; Peterson B; Wilhelm C; Rood J; Berkley A; Cogliano NA; Liang CJ; Tesselaar K; Miedema F; Bess J; Lifson J; Connors M
PLoS One; 2019; 14(12):e0225806. PubMed ID: 31830058
[TBL] [Abstract][Full Text] [Related]
13. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
14. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors.
Agrawal S; Gupta S
J Clin Immunol; 2011 Feb; 31(1):89-98. PubMed ID: 20821041
[TBL] [Abstract][Full Text] [Related]
15. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
Simchoni N; Cunningham-Rundles C
J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
17. Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cells.
Pauls E; Shpiro N; Peggie M; Young ER; Sorcek RJ; Tan L; Choi HG; Cohen P
J Biol Chem; 2012 Jun; 287(23):19216-28. PubMed ID: 22511786
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.
Chung NP; Matthews K; Klasse PJ; Sanders RW; Moore JP
J Immunol; 2012 Dec; 189(11):5257-65. PubMed ID: 23100517
[TBL] [Abstract][Full Text] [Related]
19. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
[TBL] [Abstract][Full Text] [Related]
20. IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status.
Severa M; Rizzo F; Giacomini E; Annibali V; Gafa V; Romano S; Buscarinu MC; Fornasiero A; Salvetti M; Coccia EM
J Interferon Cytokine Res; 2015 Sep; 35(9):668-81. PubMed ID: 25923141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
